TY  - GEN
AU  - von Minckwitz,Gunter
AU  - Eidtmann,Holger
AU  - Rezai,Mahdi
AU  - Fasching,Peter A
AU  - Tesch,Hans
AU  - Eggemann,Holm
AU  - Schrader,Iris
AU  - Kittel,Kornelia
AU  - Hanusch,Claus
AU  - Kreienberg,Rolf
AU  - Solbach,Christine
AU  - Gerber,Bernd
AU  - Jackisch,Christian
AU  - Kunz,Georg
AU  - Blohmer,Jens-Uwe
AU  - Huober,Jens
AU  - Hauschild,Maik
AU  - Fehm,Tanja
AU  - Müller,Berit Maria
AU  - Denkert,Carsten
AU  - Loibl,Sibylle
AU  - Nekljudova,Valentina
AU  - Untch,Michael
TI  - Neoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancer
SN  - 1533-4406
PY  - 2012///0202
KW  - Adult
KW  - Aged
KW  - Angiogenesis Inhibitors
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Bevacizumab
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Cyclophosphamide
KW  - Disease Progression
KW  - Epirubicin
KW  - Female
KW  - Humans
KW  - Logistic Models
KW  - Mastectomy, Segmental
KW  - Medication Adherence
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - Neoplasm Staging
KW  - Receptor, ErbB-2
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1056/NEJMoa1111065
ER  -